SB 203580

Grouped product items
SizePrice Qty
5mg
$90.00
50mg
$690.00
Catalog Number : 1524762

description

SB 203580 is a p38 specific inhibitor that prevents the downstream activation of heat shock protein 27 and MAP kinase-activated protein kinase 2 (MAPKAPK2). It can have anti-proliferative activity on cytokine-activated lymphocytes and is reported to be used to enhance cardiomyocyte differentiation.
product image

Additional Information

Applications:
FA
Synonyms:
SB203580, RWJ 64809, CHEMBL10, CTK8E9223
Formulation:
Crystalline solid
Chemical Name:
4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
Molecular Formula:

C21H16FN3OS

Molecular Weight:
377.4
CAS Number
152121-47-6
Purity:
≥98%
Storage Conditions:
Product should be kept at -20°C.
References:

Lali, F. V., Hunt, A. E., Turner, S. J., & Foxwell, B. M. (2000). The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. Journal of Biological Chemistry275(10), 7395-7402.

Barancik, M., Htun, P., Strohm, C., Kilian, S., & Schaper, W. (2000). Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.Journal of cardiovascular pharmacology35(3), 474-483.

Martin, J. L., Avkiran, M., Quinlan, R. A., Cohen, P., & Marber, M. S. (2001). Antiischemic Effects of SB203580 Are Mediated Through the Inhibition of p38α Mitogen-Activated Protein Kinase Evidence From Ectopic Expression of an Inhibition-Resistant Kinase. Circulation research89(9), 750-752.

© BioGems International, Inc. All rights reserved.